Trial
NCT04111497
Glasdegib for Chronic Graft-Versus-Host Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fred Hutchinson Cancer Center
Collaborators
Pfizer
Condition
Chronic Graft Versus Host Disease
Intervention
Glasdegib
Why stopped
Study closed to accrual early due to side effects of study drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-29